Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.50 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.50 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.50 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.50 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.50 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.50 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5354754 | 1.00 | SIGMAR1 (0.50) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL4351696 | 1.00 | SIGMAR1 (0.50) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL5588010 | 0.97 | SIGMAR1 (0.48) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| Hydrochloric Acid SCHEMBL11298158 | 0.95 | SIGMAR1 (0.47) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| Hydrochloric Acid SCHEMBL11298156 | 0.95 | SIGMAR1 (0.47) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL3736651 | 0.93 | SIGMAR1 (0.46) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL7056457 | 0.93 | SIGMAR1 (0.46) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL6056657 | 0.91 | SIGMAR1 (0.44) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL6056681 | 0.91 | SIGMAR1 (0.44) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL11298160 | 0.91 | SIGMAR1 (0.44) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1110941-B1 | Process for the codimerisation of polyunsaturated fatty compounds and olefines with iron complexes | INST FRANCAIS DU PETROLE (FR) | 2004-03-17 | — | — | EP | claimed |
| US-7612245-B2 | converting 1,3-butadiene to cis-2-butene in presence of a hydrogenation catalyst mixture containing iron octanoate, triethylaluminium, 2,3-bis(2,6-dimethylphenylimino)butane; catalyst selectivity | INSTITUT FRANCAIS DU PETROLE (FR) | 2009-11-03 | — | — | US | disclosed |
| EP-1519787-B1 | METHOD FOR SELECTIVE HYDROGENATION OF POLYUNSATURATED COMPOUNDS TO MONOUNSATURATED COMPOUNDS USING A HOMOGENEOUS CATALYST | INST FRANCAIS DU PETROLE (FR) | 2008-07-09 | — | — | EP | disclosed |
| US-20060129010-A1 | Method for selective hydrogenation of polyunsaturated compounds into monounsaturated compounds using a homogeneous catalyst | INSTITUTE FRANCAIS DU PETROLE (FR) | 2006-06-15 | — | — | US | disclosed |
| EP-1519787-A1 | METHOD FOR SELECTIVE HYDROGENATION OF POLYUNSATURATED COMPOUNDS INTO MONOUNSATURATED COMPOUNDS USING A HOMOGENEOUS CATALYST | INSTITUT FRANCAIS DU PETROLE (FR) | 2005-04-06 | — | — | EP | disclosed |
| WO-2004002624-A1 | METHOD FOR SELECTIVE HYDROGENATION OF POLYUNSATURATED COMPOUNDS INTO MONOUNSATURATED COMPOUNDS USING A HOMOGENEOUS CATALYST | INSTITUT FRANCAIS DU PETROLE (FR) | 2004-01-08 | — | — | WO | disclosed |
| US-6444831-B2 | A MONOOLEFINIC COMPOUND IS ADDED TO A FATTY SUBSTANCE THAT COMPRISES TWO CONJUGATED OR UNCONJUGATED ETHYELNE BONDS IN PRESENCE OF A CATALYTIC SYSTEM CONTAINING IRON COMPOUNDS, A REDUCING AGENT, A LIGAND WHICH CONTAINS NITROGEN, ARSANIC ETC | INSTITUT FRANCAIS DU PETROLE (FR) | 2002-09-03 | — | — | US | disclosed |
| US-20010005758-A1 | Process for the codimerization of polyunsaturated fatty substances and olefins by iron complexes | INSTITUT FRANCAIS DE PETROLE (FR) | 2001-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060129010-A1 | Method for selective hydrogenation of polyunsaturated compounds into monounsaturated compounds using a homogeneous catalyst | PLA2G5, PLA2G2C, ELOVL6 | SIGMAR1 614/4885GRIN2D 333/4885GRIN3B 483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.